3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
3
Meningioma
3
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Radiation Injuries
2
Pituitary Neoplasms
2
Nerve Sheath Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Wilms Tumor
1
Vascular Neoplasms
1
Uterine Cervical Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Resectable Lung Non-Small Cell Carcinoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neurilemmoma
1
Neoplasms, Adipose Tissue
1
Nasopharyngeal Carcinoma
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Interventions
Radiotherapy
3
pembrolizumab
2
fludarabine
2
Drug Therapy
2
Cyclophosphamide
2
zimberelimab
1
lenvatinib
1
envafolimab
1
Thymectomy
1
Thoracic Surgery, Video-Assisted
1
Radiotherapy, Adjuvant
1
Proton Therapy
1
Paclitaxel
1
Methylprednisolone
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Carboplatin
1
Bupivacaine
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Thymoma
×
Proton Therapy
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled